Berkeley Capital Partners, LLC Bluebird Bio, Inc. Transaction History

Berkeley Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$99.64 - $127.59 $198,383 - $254,031	-1,991 Closed	0 $0
Q1 2018 Apr 27, 2018	SELL	$105.8 - $150.94 $27,825 - $39,697	-263 Reduced 11.67%	1,991 $339,000
Q4 2017 Feb 02, 2018	SELL	$81.25 - $130.7 $13,893 - $22,349	-171 Reduced 7.05%	2,254 $401,000
Q3 2017 Nov 08, 2017	BUY	$57.74 - $91.42 $140,019 - $221,693	2,425	2,425 $333,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Berkeley Capital Partners, LLC with notifications on news.